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ABSTRACT 
Objective: To develop and validate simple, accurate, rapid, precise, reproducible and cost effective spectrophotometric method for the quantitative 
estimation of carbamazepine in a pharmaceutical formulation. 
Methods: The developed UV spectrophotometric method for the quantitative estimation of carbamazepine is based on measurement of absorption 
at maximum wavelength 284 nm using methanol as a solvent. The stock solution of carbamazepine was prepared, and subsequent suitable dilution 
was prepared in distilled water to obtained standard curve. The standard solution of carbamazepine shows absorption maxima at 284 nm. 
Results: The drug obeyed beer lambert’s law in the concentration range of 2-14 µg/ml with regression 0.9997 at 284 nm. The overall % recovery 
was found to be 99.99% which reflects that the method was free from the interference of the impurities and other excipients used in the 
formulation. The low value of % RSD was indicative of accuracy and reproducibility of the method. The % RSD for inter-day and intra-day precision 
was found to be 0.1568 and 0.1746 respectively which is<2% hence proved that method is precise. 
Conclusion: The results of analysis have been validated as per International Conference on Harmonization (ICH) guidelines. The developed method 
can be adopted in routine analysis of carbamazepine in tablet dosage form as well bulk dosage form. 
Keywords: Carbamazepine, UV Spectrophotometry, Method development, Validation, ICH guidelines, Methanol. 
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INTRODUCTION 
Carbamazepine, 5H dibenzo (b, f) azepine-5-carboxamide (fig. 1) is 
an antiepileptic drug and it is the drug of choice for treatment of 
grand mal and psychomotor epilepsy. It is considered to be one of 
the most vital drugs for the relief of pain associated with trigeminal 
neuralgia [1-2]. Carbamazepine is related chemically to the tricyclic 
antidepressants. It is a derivative of iminostilbene with a carbamoyl 
group at the 5 position; this moiety is essential for potent antiseizure 
activity [3-4]. It is a white or almost white, crystalline powder, 
practically insoluble in water, freely soluble in methylene chloride, 
sparingly soluble in acetone and in alcohol, practically insoluble in 
ether. It shows polymorphism. Carbamazepine is official in IP, USP, 
BP etc. [5-7]. As per investigation of literature, the UV spectro-
photometric, HPLC analytical method were developed on different 
wavelength for analysis of Carbamazepine in plasma fluids, Human 
serum, Plasma and pharmaceutical tablet dosage form or bulk drug 
samples [8-11]. The rational of this work to develop a simple, 
accurate, rapid, precise, reproducible and cost effective spectro-
photometric method for the direct quantitative determination of 
carbamazepine. In this method, we developed a method for 
determination carbamazepine in bulk drug sample and tablet dosage 
form and validation as per International Conference on 






Fig. 1: Chemical structure of carbamazepine 
MATERIALS AND METHODS 
Instrument 
Shimadzu UV1700 pharma spec double beam spectrophotometer 
with UV Probe software version 2 was used to develop the analytical 
method. The above instruments had automatic wavelength accuracy 
0.1 nm and matched quartz cells with 1 cm cell path length, 
Ultrasonicator (Spectra lab UCB 40, India) and Weighing balance 
(Shimadzu, Japan) were used for this work. 
Material 
Carbamazepine was gifted from Swapnroop Drugs and 
Pharmaceutical, Aurangabad, India. The commercially available 
tablets Tegretol®CR 400 mg (Batch No.156014), Tegretol®CR 200 
mg (Batch No.156021ME) Tegretol® 
Method development 
Chewable 100 mg (Batch 
No.142009EH) Novartis India Ltd. were obtained from the market. 
Methanol (HPLC Grade) was used as a solvent was obtained from 
Fisher Scientific, India. The Aerosil 200 was obtained from Evonik 
Industries and Distilled water was used obtained from Water 
purification unit. 
Preparation of Standard solution  
A Standard stock solution was prepared by accurately weighed 25 
mg of carbamazepine in 25 ml of volumetric flask and dissolved in 
Methanol to obtain a concentration 1 mg/ml or 1000 µg/ml 
(standard Stock I). Further diluting 2.5 mL of stock solution to 25 ml 
with distilled water to get desired concentration of 100 µg/ml 
(standard Stock II) [12-14]. 
Selection of wavelength for analysis of carbamazepine 
Accurately measured 1 ml of standard stock II solution was 
transferred into 10 ml volumetric flask and diluted to 10 ml to give 
concentration of 10 µg/ml and it was used for initial spectral scan in 
the UV range of 400-200 nm to detect maximum wavelength and 
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further dilutions for linearity were prepared from the stock solution 
by allegation method. 
Preparation of serial dilutions 
The serial dilutions were prepared from the standard stock II 
solution to get a respective concentration of 2,4,6,8 up to 14 µg/ml. 
Method validation 
The proposed method was validated for various parameters such as 
linearity and range, accuracy, precision, limit of detection (LOD), 
limit of quantitation (LOQ), robustness, ruggedness, sensitivity and 
specificity according to ICH Q2 (R1) guideline and USP guidelines 
[15-16]. 
Linearity and range 
The linearity of an analytical procedure is its ability (within a given 
range) to obtain test result which are directly proportional to the 
concentration of an analyte in the sample. The range of an analytical 
procedure is the interval between the upper and lower 
concentration of an analyte in the sample for which it has been 
demonstrated that the analytical procedure has a suitable level of 
precision, accuracy and linearity. The linearity of the analytical 
method was demonstrated over the concentration range 
investigated by triplicate analysis (n = 3) at a concentration range of 
2-14 µg/ml. The absorbance obtained at respective concentration 
was recorded, and the graph is plotted as concentration (µg/ml) 
versus absorbance. The linear regression equation and the 
coefficient correlation were obtained from the UV probe software. 
Accuracy 
The accuracy of an analytical procedure expresses the closeness of 
agreement between the value which is accepted either as a 
conventional true value or an accepted reference value and the value 
found. This is sometimes termed trueness. The accuracy of proposed 
method was determined on the basis of recovery study. Recovery 
study was carried out by spiking standard working solution to sample 
solution (formulation) at three different levels 80%, 100% and 120%. 
The final concentration of carbamazepine was determined at each 
levels of the amount; three determinations were performed. The 
percentage recovery was calculated as mean±standard deviation. 
Precision  
The precision of an analytical procedure expresses the closeness of 
agreement (degree of scatter) between a series of measurements 
obtained from multiple sampling of the homogeneous sample under 
the prescribed conditions. The precision of the method was 
demonstrated by intra-day and inter-day variation studies. In the 
intra-day precision study, three different solutions of same 
concentration were prepared and analysed in the same day 
(morning, noon and evening), whereas in the inter-day precision 
study, the solutions of same concentration were prepared and 
analysed, for three consecutive days, and the absorbances were 
recorded. All study was performed in triplicates. The result was 
indicated by calculating % RSD.  
Limit of detection (LOD) 
The detection limit of an individual analytical procedure is the 
lowest amount of analyte in a sample, which can be detected, but not 
necessarily quantitated as an exact value. 
The limit of detection (LOD) was determined by preparing solutions 
of different concentrations from 2-14µg/ml.  




Limit of quantification (LOQ) 
The detection limit is the lowest amount of analyte in a sample 
which can be detected but not quantitates. The LOQ was calculated 
using the formula involving the standard deviation of response and 
the slope of the calibration curve. 





The sensitivity of the method was determined by calculating the 
different parameter like molar absorptivity and Sandell's sensitivity.  
Robustness 
The robustness of an analytical procedure is a measure of its 
capacity remains unaffected by small, but deliberate variations in 
method parameters and provides an indication of its reliability 
during normal usage. The robustness of the proposed method the 
solutions of 2µg/ml of standard carbamazepine solution was 
prepared and analysed by a change in wavelength. The wavelength 
was selected λmax ± 1 i.e. 283 and 285 nm respectively for standard 
carbamazepine solution. 
Ruggedness 
The ruggedness is a degree of reproducibility of test result under 
verification of condition like a different analyst, different 
instruments and different days. 
To establish ruggedness of the proposed method, the solutions of 2 
µg/ml of standard carbamazepine solution was prepared and 
analysed with the change in the different analyst. 
Specificity 
Specificity is the ability to assess the analyte unequivocally in the 
presence of components which may be expected to be present. 
Typically these might include impurities, degradant, matrix, etc. For 
this study specificity was done by using an excipient Aerosil 200. 
The three different concentrations at three levels 80%, 100%, 120% 
respectively of standard carbamazepine (5µg/ml) spiked on Aerosil 
sample. At each level of the amount, the triplicate study was 
performed to check the effect of Aerosil 200. 
RESULTS AND DISCUSSION 
Selection of wavelength 
The spectra of carbamazepine in methanol showed absorption at 
284 nm shown in fig. 2, which is complying with reported λmax. 
Hence, it was selected as λmax 
 
of carbamazepine in methanol: 
distilled water for further use. 
 
Fig. 2: UV spectrum of carbamazepine 
 
Linearity and range 
The linearity for the developed method was investigated by replicate 
analysis (n=3) at seven concentration levels (2-14 µg/ml) of 
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reference standard carbamazepine. The absorbance obtained at 
respective concentration was recorded and graph was plotted shows 
good linear correlation coefficient from the UV probe software. The 
linearity was shown in table 1 and fig. 3. 
 
Table 1: Calibration curve data of carbamazepine 











The accuracy was determined in triplicate by analysing % recovery 
of carbamazepine by standard addition method. The percent 
recovery obtained indicates non-interference from the excipients 
used in the formulation. The results were shown in table 2. 
Method precision 
The precision of proposed method was determined by Intra-day and 
Inter-day precision, and it was expressed in terms of percent relative 
standard deviation (%RSD). For Inter-day and Intra-day %RSD were 




Fig. 3: Calibration curve of carbamazepine 
 
Table 2: Accuracy results of carbamazepine 













%Recovery Mean % recovery 
±SD 
%RSD 
 5 4 9 8.987 99.8555  
99.9148±0.0513 
0.0513 
80 5 4 9 8.987 99.9444 
 5 4 9 8.995 99.9444 
 5 5 10 10.022 100.22  
100.1733±0.0642 
0.0641 
100 5 5 10 10.01 100.1 
 5 5 10 10.02 100.2 
 5 6 11 10.926 99.3272  
99.9090±0.8847 
0.8855 
120 5 6 11 11.102 100.9273 
 5 6 11 10.942 99.4727 
 
Table 2: Inter-day precision 
Mean absorbance mean±SD %RSD Mean %RSD 
0.8256 0.8244±0.0012 0.1526  
0.8231 
0.8246 
0.8256 0.8245±0.0014 0.1742 
0.8251 0.1568 
0.8229  




Table 3: Intra-day precision 
S. No. Mean Absorbance mean±SD %RSD Mean %RSD 
 
1 














Limit of detection (LOD) and limit of quantitation (LOQ) 
Limit of detection 
The limits of detection (LOD) which represent the sensitivity of the 
proposed method were determined. The LOD value obtained was 
0.4439 µg/ml. It indicates the high sensitivity of the proposed method. 
Limit of quantitation 
The limits of Quantitation (LOQ) which represent the sensitivity of 
the proposed method were determined.  
The LOQ value obtained was 1.267 µg/ml. It indicates the high 
sensitivity of the proposed method. 
Zadbuke et al. 




In the ruggedness study, the influence of small, deliberate variations of 
the analytical parameters on the absorbance of the drug was examined.  
The factor selected was a change in the analyst. The result of ruggedness 
study indicates that the selected factor remained unaffected by small 
variations with % RSD of 0.4429-0.4452, which confirms the ruggedness 
of method. The results were summarized in table 5. 
 
Table 4: Ruggedness data for carbamazepine 
Observation Analyst 1 Analyst 2 
Absorbance 0.13 0.13 
Mean 0.1303 ∗ 0.1296 
SD 0.0005 0.0005 
%RSD 0.4429 0.4452 
 *(n=3) 
 
Table 5: Robustness data for carbamazepine 
Wavelength (nm) Absorbance Mean absorbance±SD %RSD 




0.0768 283 0.1300 
283 0.1301 




0.0887 284 0.1303 
284 0.1301 
285 0.1301  
0.1301±0.0001 
 




Robustness of this method was determined by analysing the standard 
carbamazepine solution of 2 μg/ml at a different wavelength (i.e. λ 
max±1). Absorbance was measured. The standard deviation and 
percent relative standard deviation was calculated. Results of 
robustness study indicate that the selected factor remained unaffected 
by small variation with RSD 0.0768-0.0887 confirms the robustness of 
the method. Results were shown in table 6. 
Sensitivity 
The developed method showed the high molar absorptivity value i.e. 
15471, which indicated that it absorb light very effectively at the 
appropriate wavelength and hence low concentrations of a 
compound can be easily detected. Sandell’s sensitivity value i.e. 
0.0152 µg/cm2 
Specificity 
suggested that the carbamazepine can be detected in 
the very low concentration at a path length of 1 cm. Both the above 
parameter will prove the sensitivity of drug and method developed 
at the specific wavelength at a specific concentration. 
The specificity of proposed method was ascertained by performing 
the study at three concentration levels of aerosol 200 i.e. 80%, 100% 
and 120%. The percent recovery obtained indicates non-
interference from the excipients in the formulation. The results of 
specificity study were given in table 7. 
 
Table 6: Specificity study 






Absorbance Drug recovered 
(µg/ml) 
% Recovery Mean % 
Recovery 
 5 4 9 0.2958 5.00 100.00  
100.00 80 5 4 9 0.2958 5.00 100.00 
 5 4 9 0.2959 5.001 100.0338 
 5 5 10 0.2958 5.00 100.00  
99.9887 100 5 5 10 0.296 5.0033 100.0676 
 5 5 10 0.2955 4.9949 99.89858 
 5 6 11 0.2959 5.0016 100.0338  
100.00 120 5 6 11 0.2956 4.9966 99.93238 
 5 6 11 0.2959 5.0016 100.0338 
 
Table 7: Assay of tablet dosage form 







Tegretol® 10 CR400 mg Novartis India Ltd. 100.23 100.15±0.1473 0.1470 
10 100.24 
10 99.98 
Tegretol® 10 CR200 mg, Novartis India Ltd. 100.1 100.08± 0.1205 0.1204 
10 99.96 
10 100.2 
Tegretol® 10 100 mg Chewable, Novartis India Ltd. 100.59 100.22± 0.3507 0.3499 
10 100.20 
10 99.89 
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Table 8: Summary of validation parameters 
Parameters Results 
λmax (nm) 284 
Linearity range (μg/ml) 2-14 
Regression equation y = 0.0583x+0.0033 
Correlation coefficient (r2 0.9997 ) 
Precision 
Inter-day precision (%RSD) 























Assay of marketed tablet formulation 
Twenty tablets were accurately weighed, and average weight was 
calculated, they were crushed to fine powder. The powder 
equivalent to 25 mg carbamazepine was dissolved in 15 ml of 
methanol with the help of sonication and volume was made up using 
methanol up to the mark of 25 ml volumetric flask. The solution was 
filtered using Whatman filter paper. This solution was further 
diluted to obtain 10 μg/ml concentration of the solution by using 
distilled water as a solvent and observed by UV analysis. This 
procedure was repeated in triplicate.  
The observed assay for commercially available tablets Tegretol®CR 
400 mg, Tegretol®CR 200 mg and Tegretol® 
1. Tripathi KD. Drugs for Central Nervous System, Essentials of 
Medical Pharmacology. New Delhi: Jaypee; 2013. 
Chewable 100 mg and 
validation parameters were summarized in table 8 and 9 respectively. 
CONCLUSION 
The simple, rapid, precise, and economical spectrophotometric 
method has been developed for the quantitative estimation of 
carbamazepine in Bulk and pharmaceutical formulation. The method 
is validated as per the ICH and USP guidelines, and it is found that 
the developed method is robust and sensitive. Hence, this method 
can be successfully and suitably acquired for routine quality control 
analysis of carbamazepine in bulk and pharmaceutical dosage form.  
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